Special Issue
Cellular therapy and vaccine development
Submission Deadline: 31 December 2011
Articles: 6
Special Issue Editor
Guest Editor
Garnet Suck
Research Scientist -, Centre for Transfusion Medicine, 11 Outram Road, Singapore 169078
Expertise: 13 publications, 2 grants, Editor of Managing Editor - Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see

here.

Keywords
Cell Biology, Molecular Biology, Technology, Therapeutics
Share This Special Issue
Published Papers (6 papers)
Open Access
Article
Cancer vaccine development: designing tumor cells for greater immunogenicity
Erica N Bozeman, Rangaiah Shashidharamurthy, Simon A Paulos, Ravi Palaniappan, Martin D'Souza, Periasamy Selvaraj
Frontiers in Bioscience-Landmark Volume 15 Issue 1, pp.309-320
Managing Editor: Garnet Suck
DOI: 10.2741/3622 Published: 01 January 2010
Open Access
Article
Dendritic cells as therapeutic agents against cancer
Erika A Eksioglu, Sarah Eisen, Vijay Reddy
Frontiers in Bioscience-Landmark Volume 15 Issue 1, pp.321-347
Managing Editor: Garnet Suck
DOI: 10.2741/3623 Published: 01 January 2010
Open Access
Article
Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials
Severine Loisel-Meyer, Ronan Foley, Jeffrey A Medin
Frontiers in Bioscience-Landmark Volume 13 Issue 9, pp.3202-3214
Managing Editor: Garnet Suck
DOI: 10.2741/2921 Published: 01 May 2008
Open Access
Article
Macrophages and cancer
Alessandra Nardin, Jean-Pierre Abastado
Frontiers in Bioscience-Landmark Volume 13 Issue 9, pp.3494-3505
Managing Editor: Garnet Suck
DOI: 10.2741/2944 Published: 01 May 2008
Open Access
Article
CD137, implications in immunity and potential for therapy
Elaine Thum, Zhe Shao, Herbert Schwarz
Frontiers in Bioscience-Landmark Volume 14 Issue 11, pp.4173-4188
Managing Editor: Garnet Suck
DOI: 10.2741/3521 Published: 01 January 2009
Open Access
Article
Cancer vaccines: Uses of HLA transgenic mice compared to genetically modified mice
Stephanie McArdle
Frontiers in Bioscience-Landmark Volume 14 Issue 12, pp.4640-4651
Managing Editor: Garnet Suck
DOI: 10.2741/3556 Published: 01 January 2009